Results 111 to 120 of about 6,026 (204)

Cefiderocol Heteroresistance in NDM-Producing Enterobacterales: A Complex Polymicrobial Infection Successfully Salvaged With Ceftazidime-Avibactam Plus Aztreonam. [PDF]

Am J Case Rep
Nuaimi M, Cirillo J, Usbosy S, Egan D, Kovacich A, Madruga M, Carlan SJ.   +6 more
europepmc   +1 more source

Synergistic activity of cefepime/enmetazobactam with meropenem, piperacillin, piperacillin/tazobactam, cefiderocol and fosfomycin against Klebsiella pneumoniae carrying blaKPC allelic variants. [PDF]

J Antimicrob Chemother
Crema A, Shafique A, Bianco G, Gaibani P.   +3 more
europepmc   +1 more source

In Vitro Activity of Cefiderocol, Eravacycline, and Imipenem-Relebactam Against Multidrug-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates. [PDF]

Antibiotics (Basel)
Bölükbaşı Y, Öngen B.
europepmc   +1 more source

Cefiderocol resistance in a clinical ST11-KL64 hypervirulent Klebsiella pneumoniae isolate mediated by a novel CirA truncation and SHV-12 β-lactamase. [PDF]

BMC Microbiol
Zhou P, Fu J, He X, Gao H, Wu C, Yu F, Zhou Y.   +6 more
europepmc   +1 more source

Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol [PDF]

Bianco, G., Boattini, M., Comini, S.
core   +1 more source

An immune-mediated effect of the antibiotic cefiderocol on LPS-induced acute lung injury. [PDF]

Antimicrob Agents Chemother
Hao M, Li Y, Bi Y, Liu S, Ju M.
europepmc   +1 more source

Cefiderocol Susceptibility and Carbapenemase Profiles in Carbapenem-Resistant Enterobacterales. [PDF]

Infect Dis Clin Microbiol
Bayrak A, Akçalı A, Mutlu R, Çakıcı N.   +3 more
europepmc   +1 more source

Structural Insights Into the Molecular Mechanism of High-Level Ceftazidime-Avibactam Resistance Conferred by Cmy-185 [PDF]

β-Lactamases can accumulate stepwise mutations that increase their resistance profiles to the latest β-lactam agents. CMY-185 is a CMY-2-like β-lactamase and was identified in an Escherichia coli clinical strain isolated from a patient who underwent ...
Aitken, Samuel L, Bachman, William C, Bhatti, Micah M, Borjan, Jovan, Doi, Yohei, Kawai, Akito, McElheny, Christi L, Shelburne, Samuel A, Shields, Ryan K, Shropshire, William C, Suzuki, Masahiro   +10 more
core   +1 more source

Role of Cefiderocol in the Treatment of Carbapenem-Resistant Nonfermenting Gram-Negative Bacilli (Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia) Infections: An Expert Statement. [PDF]

Infect Dis Ther
Bleibtreu A, Bennis Y, Dinh A, Dupont H, Friggeri A, Jeannot K, Kipnis E, Zahar JR, CoRIS Cohort.   +8 more
europepmc   +1 more source

A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant <i>Achromobacter xylosoxidans</i>. [PDF]

Antimicrob Agents Chemother
Arun B, Sharma R, Vallé Q, Bui NM, Furtado N, Ramirez MS, Rao G.   +6 more
europepmc   +1 more source